BioCentury
ARTICLE | Clinical News

Enzon, Santaris preclinical data

November 23, 2009 8:00 AM UTC

EZN-3892 and EZN-3889 each significantly down-modulated beta-catenin mRNA and protein in multiple tumor cell lines and in mouse models of liver cancer. Data were presented at the AACR-NCI-EORTC Inter...